BioCentury
ARTICLE | Company News

Management tracks

April 28, 2015 1:23 AM UTC

Diagnostics company Invitae Corp. (NYSE:NVTA) named Robert Nussbaum CMO, effective Aug. 1. Nussbaum was chief of the division of genomic medicine at the University of California San Francisco Medical Center; he will continue clinical activities as a volunteer physician at UCSF.

Gene editing company Editas Medicine (Cambridge, Mass.) hired Vic Myer as CTO, a newly created position. Myer was an executive director and the Cambridge site head for the developmental and molecular pathways department at the Novartis Institutes for BioMedical Research (NIBR). ...